MedPath

Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections

Not Applicable
Conditions
Dysentery
Interventions
Other: Laboratory Tests
Registration Number
NCT01638039
Lead Sponsor
Hillel Yaffe Medical Center
Brief Summary

The aim of this study is to accelerate the development of vaccine candidates against diarrheal diseases caused by Shigella and Enterotoxigenic Escherichia coli (ETEC). We plan to identify cases of laboratory-proven shigellosis and ETEC-associated diarrhea, to study humoral and cellular immune parameters following natural infections with Shigella and ETEC, and to compare the level of pre-existing local, humoral and cellular immune parameters in cases of shigellosis and ETEC-associated diarrhea and in matched controls.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
330
Inclusion Criteria
  • Lab-confirmed Shigella or ETEC
  • Individuals or patients without diarrheal disease
Exclusion Criteria
  • n/a

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Diarrheal diseaseLaboratory Tests-
ControlLaboratory TestsSamples of stool, blood, urine saliva
Primary Outcome Measures
NameTimeMethod
Identification of cases of shigellosis and ETEC-associated diarrheaFour years

Stool of patients examined in laboratory and identified as infected with the pathogens

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (7)

Edith Wolfson Medical Center

🇮🇱

Holon, Israel

Emek Medical Center

🇮🇱

Afula, Israel

Hillel Yaffe Medical Center

🇮🇱

Hadera, Israel

Leumit Health Care System

🇮🇱

Petach Tikvah, Elad, Israel

Lady Davis Carmel Medical Center

🇮🇱

Haifa, Israel

Sansz Medical Center - Laniado Hospital

🇮🇱

Netanya, Israel

Schneider Children's Medical Center

🇮🇱

Petach Tikva, Israel

© Copyright 2025. All Rights Reserved by MedPath